Table 2

Summary of adverse events

Adverse events, n = 40All grades, n (%)Grade 1/2, n (%)Grade 3/4, n (%)
Myelosuppression (hematology)27 (67.5)21 (52.5)6 (15.0)
Leukopenia22 (55.0)20 (50.0)2 (5.0)
Neutropenia22 (55.0)17 (42.5)5 (12.5)
Thrombocytopenia10 (25.0)9 (22.5)1 (2.5)
Decreased hemoglobin9 (22.5)9 (22.5)0 (0)
Gastrointestinal reaction28 (70.0)19 (47.5)9 (22.5)
Nausea23 (57.5)22 (55.0)1 (2.5)
Diarrhea19 (47.5)13 (32.5)6 (15.0)
Vomiting12 (30.0)10 (25.0)2 (5.0)
Hypertension25 (62.5)15 (37.5)10 (25.0)
Pain24 (60.0)19 (47.5)5 (12.5)
Malaise21 (52.5)19 (47.5)2 (5.0)
Anorexia20 (50.0)19 (47.5)1 (2.5)
Elevated transaminase19 (47.5)19 (47.5)0 (0)
Hand-foot skin reaction19 (47.5)16 (40.0)3 (7.5)
Proteinuria15 (37.5)14 (35.0)1 (2.5)
Elevated bilirubin13 (32.5)12 (30.0)1 (2.5)
Mucositis11 (27.5)8 (20.0)3 (7.5)
Hemorrhage8 (20.0)7 (17.5)1 (2.5)
Sinus tachycardia6 (15.0)6 (15.0)0 (0)
Elevated creatinine3 (7.5)3 (7.5)0 (0)